About SCRI

about SCRI

The Singapore Clinical Research Institute (SCRI) is a national academic research organisation dedicated to enhancing the standards of human clinical research.

As a wholly-owned subsidiary of MOH Holdings, we strive to improve patient care through the design and conduct of cutting-edge clinical research. The highly experienced scientists and operations team at SCRI works closely with our partners, including leading pharmaceutical, medical devices and biotech, as well as academic Investigators.

News and Workshops

Live Interview on First Look Asia by Channel NewsAsia on World Diabetes Day

Our CEO, Associate Professor Teoh Yee Leong and Endocrinologist, Dr Daniel Wai Chun Hang from Mount Elizabeth Hospital were featured ‘LIVE’ on First Look Asia by Channel NewsAsia at 8.45 a.m on World Diabetes Day, 14 November 2016.   During the 2-hour daily breakfast programme, both shared more on the tripartite partnership involved in the […]

Media Coverage DAA-1 Study

The article highlighted that the “made in Singapore” anti-diabetic drug, DAA-I, has successfully completed its Stage I clinical trial and is the result of 20 years of extensive  research and was a joint collaboration between NUS Yong Loo Lin School of Medicine, Singapore Clinical Research Institute and the National University Health System. The article also […]

Our Collaborators

ah
ah
ah
ah
ah
ah